How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/continuation-therapy-for-chronic-osteomyelitis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Continuation Therapy for Chronic Osteomyelitis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Continuation Therapy for Chronic Osteomyelitis (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Continuation Therapy for Chronic Osteomyelitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Methocillin S	CLOXACILLIN	GSK	cloxacillin		1974-01-01
Bactocill In Plastic Container	OXACILLIN	Apothecon		Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2	1971-01-01
Pathocil	DICLOXACILLIN	Pfizer	Penicillin-class Antibacterial	Muscarinic acetylcholine receptor M1	1968-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Apothecon · 1 drug in Continuation Therapy for Chronic Osteomyelitis
GSK · 1 drug in Continuation Therapy for Chronic Osteomyelitis
Pfizer · 1 drug in Continuation Therapy for Chronic Osteomyelitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Continuation Therapy for Chronic Osteomyelitis:

Cite this brief

Drug Landscape (2026). Continuation Therapy for Chronic Osteomyelitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/continuation-therapy-for-chronic-osteomyelitis. Accessed 2026-06-10.

Continuation Therapy for Chronic Osteomyelitis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing